Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 3 1Phase 2 1

Status

Completed 5Recruiting 3Not yet recruiting 3Withdrawn 2Terminated 2Unknown 1

Sponsor Class

OTHER 2OTHER_GOV 1

Study Type

Interventional 3Observational 1

Sponsor

Cancer Type

Head & Neck 3Endocrine 1

Conditions

Thyroid Neoplasms 1Thyroid Diseases 1Thyroid Cancer, Papillary 1Advanced Differentiated Thyroid Gland Carcinoma 1

Interventions

Cisplatin 122Carboplatin 120Drug Therapy 104Bevacizumab 101Capecitabine 96Oxaliplatin 95Radiotherapy 92Gemcitabine 88Paclitaxel 87tislelizumab 84Cyclophosphamide 83Specimen Handling 80pembrolizumab 76toripalimab 66Magnetic Resonance Spectroscopy 63Fluorouracil 61sintilimab 58Injections 57anlotinib 51Docetaxel 51Surgical Procedures, Operative 48130-nm albumin-bound paclitaxel 48fludarabine 45Pemetrexed 43Standard of Care 42Biopsy 42venetoclax 41Irinotecan 41lenvatinib 40Leucovorin 40

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Not yet recruiting × Interventional × Thyroxine × Clear all
NCT06790589 2026-02-06

COACH - Comparing Two Different Methods to Suppress Thyrotropin in Patients With Advanced Thyroid Cancer

AHS Cancer Control Alberta

Phase 2 Not yet recruiting
70 enrolled
Head & Neck

Advanced Differentiated Thyroid Gland Carcinoma

NCT07239674 2025-11-20

DELTA

West China Hospital

Phase 3 Not yet recruiting
646 enrolled
Head & Neck

Thyroid Diseases

NCT06971965 2025-05-14

MAeSTro-TSH

National Cancer Center, Korea

Phase NA Not yet recruiting
578 enrolled
EndocrineHead & Neck

Thyroid Cancer, Papillary, Thyroid Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡